Reuters exclusively reports Sanofi offers to buy U.S. biotech company Translate Bio; market reacts

Reuters exclusively reported that Sanofi has offered to buy U.S. biotech company Translate Bio, as the French drugmaker bets on next-generation mRNA technology after setbacks in the COVID-19 vaccine race. Following the Reuters report, shares in the New York-listed biotech company soared more than 70% in extended trading, building on the big gains in the stock as investors have piled in to the sector amid a rush to develop vaccines and treatments to tame the pandemic. Sanofi confirmed the deal the following morning. 

The post Reuters exclusively reports Sanofi offers to buy U.S. biotech company Translate Bio; market reacts appeared first on Reuters News Agency.